Takara spins off biotech unit
Tuesday, 02 April, 2002
Japanese liquor maker Takara Shuzo has stepped up its push to make a name for itself in the biotechnology sector by separating its bio-related activities into a new company.
The split, which was completed on Monday (April 1) as the new Japanese fiscal year began, has resulted in the formation of two companies, Takara Shuzo Co Ltd and Takara Biomedical Co Ltd, under a single holding company, Takara Holdings Inc.
Otsu, Japan based Takara Biomedical includes Dragon Genomics, a genome analysis center formed last year in western Japan.
Anti-inflammatory drug may help treat alcohol use disorder
A drug that is already FDA-approved for treating inflammatory conditions may help reduce both...
Osteoarthritis study uncovers new genetic links, drug targets
The genome-wide association study (GWAS) uncovered over 900 genetic associations, more than 500...
How brain cells are affected by Tourette syndrome
US researchers have conducted a cell-by-cell analysis of brain tissue from individuals with...
